Levocetirizine Dihydrochloride 51655-0148-52
- Manufacturer
- Northwind Health Company, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 4, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA091264
Need to source Levocetirizine Dihydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Levocetirizine Dihydrochloride | 5 mg/1 |
Drug Class
Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
51655-0148-52Selected30 TABLET in 1 BOTTLE, PLASTIC (51655-148-52)